{"id":9408,"date":"2023-09-06T17:42:18","date_gmt":"2023-09-06T20:42:18","guid":{"rendered":"https:\/\/ocanal.com\/noticias\/corporativas\/ferrer-biopharma-apresenta-pesquisas-inovadoras-sobre-tratamento-pos-covid-no-congresso-da-ers-2023\/"},"modified":"2023-09-06T17:42:18","modified_gmt":"2023-09-06T20:42:18","slug":"ferrer-biopharma-apresenta-pesquisas-inovadoras-sobre-tratamento-pos-covid-no-congresso-da-ers-2023","status":"publish","type":"post","link":"https:\/\/ocanal.com\/noticias\/corporativas\/ferrer-biopharma-apresenta-pesquisas-inovadoras-sobre-tratamento-pos-covid-no-congresso-da-ers-2023\/","title":{"rendered":"Ferrer Biopharma apresenta pesquisas inovadoras sobre tratamento p\u00f3s-COVID no Congresso da ERS 2023"},"content":{"rendered":"<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nA empresa l\u00edder em pesquisa e desenvolvimento farmac\u00eautico, Dr. Ferrer Biopharma, anuncia orgulhosamente sua participa\u00e7\u00e3o no t\u00e3o aguardado <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.ersnet.org%2F&amp;esheet=53549709&amp;newsitemid=20230906450166&amp;lan=pt-BR&amp;anchor=Congresso+da+Sociedade+Europeia+de+Respira%26ccedil%3B%26atilde%3Bo+%28ERS%29+2023&amp;index=1&amp;md5=b5ccd73f81be630dc41c876b7cf49c4a\" rel=\"nofollow noopener\" shape=\"rect\" target=\"_blank\"><b>Congresso da Sociedade Europeia de Respira\u00e7\u00e3o (ERS) 2023<\/b><\/a><b>,<\/b> agendado para Mil\u00e3o, na It\u00e1lia, de 9 a 13 de setembro. Durante o evento, a empresa ir\u00e1 divulgar as mais recentes descobertas de dois ensaios cl\u00ednicos aleat\u00f3rios que lan\u00e7am luz sobre o potencial da clorfeniramina intranasal para tratar sintomas a longo prazo p\u00f3s-COVID-19.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nO Congresso da ERS serve como uma plataforma de primeira linha em sa\u00fade respirat\u00f3ria, ao apresentar os mais recentes avan\u00e7os em cuidados cl\u00ednicos, pesquisa cient\u00edfica, educa\u00e7\u00e3o e tecnologia, onde especialistas e pesquisadores ao redor do mundo compartilham conhecimentos e descobertas, que impulsionam o progresso na medicina respirat\u00f3ria.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nDestacando um estudo pioneiro, o \u00faltimo resumo da Dr. Ferrer Biopharma apresenta o maleato de clorfeniramina intranasal (iCPM) como uma estrat\u00e9gia terap\u00eautica inovadora com promissoras propriedades anti-inflamat\u00f3rias e <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.1101%2F2023.08.28.554806v1&amp;esheet=53549709&amp;newsitemid=20230906450166&amp;lan=pt-BR&amp;anchor=antivirais&amp;index=2&amp;md5=4b52bb79c36289bb994cd189c12f64b6\" rel=\"nofollow noopener\" shape=\"rect\" target=\"_blank\">antivirais<\/a> contra COVID-19 e v\u00edrus respirat\u00f3rios, abordando especificamente sintomas a longo prazo. Ao investigar os efeitos desta nova abordagem, a apresenta\u00e7\u00e3o da Dr. Ferrer aprofunda o impacto da clorfeniramina intranasal nos sintomas p\u00f3s-COVID-19, ao revelar melhorias significativas no tempo de recupera\u00e7\u00e3o cl\u00ednica e al\u00edvio de sintomas como anosmia, ageusia e tosse, conforme demonstrado pelos dois ensaios aleat\u00f3rios <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.researchsquare.com%2Farticle%2Frs-2167465%2Fv1&amp;esheet=53549709&amp;newsitemid=20230906450166&amp;lan=pt-BR&amp;anchor=ACCROS+I&amp;index=3&amp;md5=4ab2d72d0f9726042824ed4bdc439741\" rel=\"nofollow noopener\" shape=\"rect\" target=\"_blank\">ACCROS I<\/a> e <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.atsjournals.org%2Fdoi%2Fabs%2F10.1164%2Fajrccm-conference.2023.207.1_MeetingAbstracts.A5619&amp;esheet=53549709&amp;newsitemid=20230906450166&amp;lan=pt-BR&amp;anchor=ACCROS+III&amp;index=4&amp;md5=479506f5706faaedfd647c5aa4bb0f97\" rel=\"nofollow noopener\" shape=\"rect\" target=\"_blank\">ACCROS III<\/a>. O acompanhamento p\u00f3s-ensaio subsequente destaca a not\u00e1vel redu\u00e7\u00e3o dos sintomas p\u00f3s-COVID da clorfeniramina em mais de 90% em compara\u00e7\u00e3o a um placebo.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\n&#8220;Os efeitos <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.1101%2F2023.08.28.554806v1&amp;esheet=53549709&amp;newsitemid=20230906450166&amp;lan=pt-BR&amp;anchor=antiviral&amp;index=5&amp;md5=8938e98d41369ea549f437286d671c78\" rel=\"nofollow noopener\" shape=\"rect\" target=\"_blank\">antiviral<\/a> e anti-inflamat\u00f3rio do iCPM pode explicar o impacto significativo na redu\u00e7\u00e3o do tempo de recupera\u00e7\u00e3o cl\u00ednica na doen\u00e7a aguda&#8221;, disse <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fmy.clevelandclinic.org%2Fstaff%2F5068-franck-rahaghi&amp;esheet=53549709&amp;newsitemid=20230906450166&amp;lan=pt-BR&amp;anchor=Dr.+Franck+Rahaghi&amp;index=6&amp;md5=d85c684394bc5e58a77b47d712b93a77\" rel=\"nofollow noopener\" shape=\"rect\" target=\"_blank\"><b>Dr. Franck Rahaghi<\/b><\/a><b>, Professor Cl\u00ednico de Medicina e Presidente do Departamento de Cuidados Intensivos e Pulmonares da Cleveland Clinic Florida, que lidera o estudo<\/b>. &#8220;O iCPM pode ter um melhor impacto na redu\u00e7\u00e3o dos sintomas de COVID prolongada. Este tratamento reformulado poderia se tornar uma interven\u00e7\u00e3o essencial para abordar o temido problema de COVID prolongada.&#8221;<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\n&#8220;Estamos empolgados em revelar os resultados de nossa pesquisa abrangente que explora o impacto da clorfeniramina intranasal nos sintomas p\u00f3s-COVID-19 a longo prazo&#8221;, disse o Dr. Fernando Valerio, pesquisador principal.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nA participa\u00e7\u00e3o da empresa ressalta sua dedica\u00e7\u00e3o em impulsionar a inova\u00e7\u00e3o e obter a excel\u00eancia em medicina respirat\u00f3ria.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nSobre a Dr. Ferrer Biopharma:<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nA Dr. Ferrer Biopharma \u00e9 uma empresa pioneira em pesquisa e desenvolvimento farmac\u00eautico dedicada ao avan\u00e7o de medicamentos intranasais para o tratamento de tosse, resfriados, gripes e alergias. Utilizamos tecnologia avan\u00e7ada para trazer ao mercado terapias de alta qualidade, com base em evid\u00eancias e foco no cliente, originadas em beira do leito.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nPara mais informa\u00e7\u00e3o, acesse <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.drferrerbiopharma.com%2F&amp;esheet=53549709&amp;newsitemid=20230906450166&amp;lan=pt-BR&amp;anchor=DrFerrerBioPharma.com.&amp;index=7&amp;md5=f1c96647a4014fd064bbb19a063bda38\" rel=\"nofollow noopener\" shape=\"rect\" target=\"_blank\">DrFerrerBioPharma.com.<\/a><\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nO texto no idioma original deste an\u00fancio \u00e9 a vers\u00e3o oficial autorizada. As tradu\u00e7\u00f5es s\u00e3o fornecidas apenas como uma facilidade e devem se referir ao texto no idioma original, que \u00e9 a \u00fanica vers\u00e3o do texto que tem efeito legal.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230906450166r1&amp;sid=brdno&amp;distro=ftp\"><span class=\"bwct31415\"><\/span><\/p>\n<p id=\"mmgallerylink\" xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><span id=\"mmgallerylink-phrase\">Ver a vers\u00e3o original em businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20230906450166\/pt\/\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.businesswire.com\/news\/home\/20230906450166\/pt\/<\/a><\/span><\/p>\n<p><b>Contato:<\/b><\/p>\n<p><i>Daniel Fern\u00e1ndez<br \/>\n<\/i><\/p>\n<p><i>Diretor de Marketing<br \/>\n<\/i><\/p>\n<p><i>+1-954-225-7694<br \/>\n<\/i><\/p>\n<p><i><a href=\"mailto:marketing@pulmonary-institute.com\" rel=\"nofollow\" shape=\"rect\">marketing@pulmonary-institute.com<\/a><\/i><\/p>\n<p><strong>Fonte: <\/strong><a href='http:\/\/www.businesswire.com\/portal\/site\/home\/' target='_blank' rel=\"noopener\">BUSINESS WIRE<\/a><img src='https:\/\/api.dino.com.br\/v2\/news\/tr\/293086?partnerId=3197' alt=\"\" style=\"border:0px;width:1px;height:1px;\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A empresa l\u00edder em pesquisa e desenvolvimento farmac\u00eautico, Dr. Ferrer Biopharma, anuncia orgulhosamente sua participa\u00e7\u00e3o no t\u00e3o aguardado Congresso da Sociedade Europeia de Respira\u00e7\u00e3o (ERS) 2023, agendado para Mil\u00e3o, na It\u00e1lia, de 9 a 13 de setembro. Durante o evento, a empresa ir\u00e1 divulgar as mais recentes descobertas de dois ensaios cl\u00ednicos aleat\u00f3rios que lan\u00e7am [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-9408","post","type-post","status-publish","format-standard","hentry","category-noticias"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ferrer Biopharma apresenta pesquisas inovadoras sobre tratamento p\u00f3s-COVID no Congresso da ERS 2023 - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ocanal.com\/noticias\/corporativas\/ferrer-biopharma-apresenta-pesquisas-inovadoras-sobre-tratamento-pos-covid-no-congresso-da-ers-2023\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ferrer Biopharma apresenta pesquisas inovadoras sobre tratamento p\u00f3s-COVID no Congresso da ERS 2023 - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\" \/>\n<meta property=\"og:description\" content=\"A empresa l\u00edder em pesquisa e desenvolvimento farmac\u00eautico, Dr. Ferrer Biopharma, anuncia orgulhosamente sua participa\u00e7\u00e3o no t\u00e3o aguardado Congresso da Sociedade Europeia de Respira\u00e7\u00e3o (ERS) 2023, agendado para Mil\u00e3o, na It\u00e1lia, de 9 a 13 de setembro. Durante o evento, a empresa ir\u00e1 divulgar as mais recentes descobertas de dois ensaios cl\u00ednicos aleat\u00f3rios que lan\u00e7am [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ocanal.com\/noticias\/corporativas\/ferrer-biopharma-apresenta-pesquisas-inovadoras-sobre-tratamento-pos-covid-no-congresso-da-ers-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-06T20:42:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230906450166r1&amp;sid=brdno&amp;distro=ftp\" \/>\n<meta name=\"author\" content=\"DINO\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"DINO\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/ferrer-biopharma-apresenta-pesquisas-inovadoras-sobre-tratamento-pos-covid-no-congresso-da-ers-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/ferrer-biopharma-apresenta-pesquisas-inovadoras-sobre-tratamento-pos-covid-no-congresso-da-ers-2023\\\/\"},\"author\":{\"name\":\"DINO\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#\\\/schema\\\/person\\\/24f7b50e924d81f1023b69582993c0ff\"},\"headline\":\"Ferrer Biopharma apresenta pesquisas inovadoras sobre tratamento p\u00f3s-COVID no Congresso da ERS 2023\",\"datePublished\":\"2023-09-06T20:42:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/ferrer-biopharma-apresenta-pesquisas-inovadoras-sobre-tratamento-pos-covid-no-congresso-da-ers-2023\\\/\"},\"wordCount\":552,\"image\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/ferrer-biopharma-apresenta-pesquisas-inovadoras-sobre-tratamento-pos-covid-no-congresso-da-ers-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230906450166r1&amp;sid=brdno&amp;distro=ftp\",\"articleSection\":[\"Not\u00edcias Corporativas\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/ferrer-biopharma-apresenta-pesquisas-inovadoras-sobre-tratamento-pos-covid-no-congresso-da-ers-2023\\\/\",\"url\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/ferrer-biopharma-apresenta-pesquisas-inovadoras-sobre-tratamento-pos-covid-no-congresso-da-ers-2023\\\/\",\"name\":\"Ferrer Biopharma apresenta pesquisas inovadoras sobre tratamento p\u00f3s-COVID no Congresso da ERS 2023 - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/ferrer-biopharma-apresenta-pesquisas-inovadoras-sobre-tratamento-pos-covid-no-congresso-da-ers-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/ferrer-biopharma-apresenta-pesquisas-inovadoras-sobre-tratamento-pos-covid-no-congresso-da-ers-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230906450166r1&amp;sid=brdno&amp;distro=ftp\",\"datePublished\":\"2023-09-06T20:42:18+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#\\\/schema\\\/person\\\/24f7b50e924d81f1023b69582993c0ff\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/ferrer-biopharma-apresenta-pesquisas-inovadoras-sobre-tratamento-pos-covid-no-congresso-da-ers-2023\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/ferrer-biopharma-apresenta-pesquisas-inovadoras-sobre-tratamento-pos-covid-no-congresso-da-ers-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/ferrer-biopharma-apresenta-pesquisas-inovadoras-sobre-tratamento-pos-covid-no-congresso-da-ers-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230906450166r1&amp;sid=brdno&amp;distro=ftp\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230906450166r1&amp;sid=brdno&amp;distro=ftp\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/ferrer-biopharma-apresenta-pesquisas-inovadoras-sobre-tratamento-pos-covid-no-congresso-da-ers-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ferrer Biopharma apresenta pesquisas inovadoras sobre tratamento p\u00f3s-COVID no Congresso da ERS 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#website\",\"url\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/\",\"name\":\"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\",\"description\":\"Tudo sobre o mercado empresarial, comunicados e neg\u00f3cios\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#\\\/schema\\\/person\\\/24f7b50e924d81f1023b69582993c0ff\",\"name\":\"DINO\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g\",\"caption\":\"DINO\"},\"url\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/author\\\/dino\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ferrer Biopharma apresenta pesquisas inovadoras sobre tratamento p\u00f3s-COVID no Congresso da ERS 2023 - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ocanal.com\/noticias\/corporativas\/ferrer-biopharma-apresenta-pesquisas-inovadoras-sobre-tratamento-pos-covid-no-congresso-da-ers-2023\/","og_locale":"pt_BR","og_type":"article","og_title":"Ferrer Biopharma apresenta pesquisas inovadoras sobre tratamento p\u00f3s-COVID no Congresso da ERS 2023 - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","og_description":"A empresa l\u00edder em pesquisa e desenvolvimento farmac\u00eautico, Dr. Ferrer Biopharma, anuncia orgulhosamente sua participa\u00e7\u00e3o no t\u00e3o aguardado Congresso da Sociedade Europeia de Respira\u00e7\u00e3o (ERS) 2023, agendado para Mil\u00e3o, na It\u00e1lia, de 9 a 13 de setembro. Durante o evento, a empresa ir\u00e1 divulgar as mais recentes descobertas de dois ensaios cl\u00ednicos aleat\u00f3rios que lan\u00e7am [&hellip;]","og_url":"https:\/\/ocanal.com\/noticias\/corporativas\/ferrer-biopharma-apresenta-pesquisas-inovadoras-sobre-tratamento-pos-covid-no-congresso-da-ers-2023\/","og_site_name":"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","article_published_time":"2023-09-06T20:42:18+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230906450166r1&amp;sid=brdno&amp;distro=ftp","type":"","width":"","height":""}],"author":"DINO","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"DINO","Est. tempo de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/ferrer-biopharma-apresenta-pesquisas-inovadoras-sobre-tratamento-pos-covid-no-congresso-da-ers-2023\/#article","isPartOf":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/ferrer-biopharma-apresenta-pesquisas-inovadoras-sobre-tratamento-pos-covid-no-congresso-da-ers-2023\/"},"author":{"name":"DINO","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#\/schema\/person\/24f7b50e924d81f1023b69582993c0ff"},"headline":"Ferrer Biopharma apresenta pesquisas inovadoras sobre tratamento p\u00f3s-COVID no Congresso da ERS 2023","datePublished":"2023-09-06T20:42:18+00:00","mainEntityOfPage":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/ferrer-biopharma-apresenta-pesquisas-inovadoras-sobre-tratamento-pos-covid-no-congresso-da-ers-2023\/"},"wordCount":552,"image":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/ferrer-biopharma-apresenta-pesquisas-inovadoras-sobre-tratamento-pos-covid-no-congresso-da-ers-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230906450166r1&amp;sid=brdno&amp;distro=ftp","articleSection":["Not\u00edcias Corporativas"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/ferrer-biopharma-apresenta-pesquisas-inovadoras-sobre-tratamento-pos-covid-no-congresso-da-ers-2023\/","url":"https:\/\/ocanal.com\/noticias\/corporativas\/ferrer-biopharma-apresenta-pesquisas-inovadoras-sobre-tratamento-pos-covid-no-congresso-da-ers-2023\/","name":"Ferrer Biopharma apresenta pesquisas inovadoras sobre tratamento p\u00f3s-COVID no Congresso da ERS 2023 - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","isPartOf":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/ferrer-biopharma-apresenta-pesquisas-inovadoras-sobre-tratamento-pos-covid-no-congresso-da-ers-2023\/#primaryimage"},"image":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/ferrer-biopharma-apresenta-pesquisas-inovadoras-sobre-tratamento-pos-covid-no-congresso-da-ers-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230906450166r1&amp;sid=brdno&amp;distro=ftp","datePublished":"2023-09-06T20:42:18+00:00","author":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#\/schema\/person\/24f7b50e924d81f1023b69582993c0ff"},"breadcrumb":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/ferrer-biopharma-apresenta-pesquisas-inovadoras-sobre-tratamento-pos-covid-no-congresso-da-ers-2023\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ocanal.com\/noticias\/corporativas\/ferrer-biopharma-apresenta-pesquisas-inovadoras-sobre-tratamento-pos-covid-no-congresso-da-ers-2023\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/ferrer-biopharma-apresenta-pesquisas-inovadoras-sobre-tratamento-pos-covid-no-congresso-da-ers-2023\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230906450166r1&amp;sid=brdno&amp;distro=ftp","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230906450166r1&amp;sid=brdno&amp;distro=ftp"},{"@type":"BreadcrumbList","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/ferrer-biopharma-apresenta-pesquisas-inovadoras-sobre-tratamento-pos-covid-no-congresso-da-ers-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/ocanal.com\/noticias\/corporativas\/"},{"@type":"ListItem","position":2,"name":"Ferrer Biopharma apresenta pesquisas inovadoras sobre tratamento p\u00f3s-COVID no Congresso da ERS 2023"}]},{"@type":"WebSite","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#website","url":"https:\/\/ocanal.com\/noticias\/corporativas\/","name":"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","description":"Tudo sobre o mercado empresarial, comunicados e neg\u00f3cios","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ocanal.com\/noticias\/corporativas\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Person","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#\/schema\/person\/24f7b50e924d81f1023b69582993c0ff","name":"DINO","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g","caption":"DINO"},"url":"https:\/\/ocanal.com\/noticias\/corporativas\/author\/dino\/"}]}},"_links":{"self":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/posts\/9408","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/comments?post=9408"}],"version-history":[{"count":0,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/posts\/9408\/revisions"}],"wp:attachment":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/media?parent=9408"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/categories?post=9408"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/tags?post=9408"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}